
Sign up to save your podcasts
Or


Dr. Doris Fuertinger, Fresenius Medical Care’s Head of Computational Medicine, discusses the use of science-based systemic modeling tools to test a spectrum of hypotheses about the future impact of novel therapeutic interventions on populations with kidney disease.
By Fresenius Medical Care, Global Medical OfficeDr. Doris Fuertinger, Fresenius Medical Care’s Head of Computational Medicine, discusses the use of science-based systemic modeling tools to test a spectrum of hypotheses about the future impact of novel therapeutic interventions on populations with kidney disease.